ASCEND BY NTHRYS
Research Abroad Products

Synthetic Biology Project Topics

Browse all focused areas across all project categories under this field.

Showing 1981–1992 of 2200 project topics
Microbial Artemisinic Acid Production Scale-Up
Optimizing semi-synthetic artemisinin production through yeast MVA pathway and CYP51 engineering and measuring titer and cost reduction achieving commercial manufacturing viability.
Synthetic Biology of Cell-Based Drug Manufacturing Click to view more details →
Opioid Precursor Biosynthetic Route Engineering
Developing yeast biosynthetic routes for thebaine and other opioid alkaloid production from simple feedstocks and measuring yield improvement and fermentation economics.
Synthetic Biology of Cell-Based Drug Manufacturing Click to view more details →
Taxol Precursor Taxadiene Biosynthetic Engineering
Engineering Taxus biosynthetic pathway modules in E. coli and yeast for improved taxadiene production and measuring precursor supply and pathway expression optimization effects.
Synthetic Biology of Cell-Based Drug Manufacturing Click to view more details →
Resveratrol and Stilbene Biosynthetic Platform Development
Engineering stilbene synthase and precursor supply pathways for resveratrol and analogue production and measuring titer improvement from systematic enzyme and pathway engineering.
Synthetic Biology of Cell-Based Drug Manufacturing Click to view more details →
Monoclonal Antibody Production Cell Line Engineering Platform
A SaaS platform that enables rapid design and optimization of Chinese Hamster Ovary (CHO) cell lines for high-yield mAb manufacturing through synthetic biology tools and predictive modeling. This platform reduces development timelines by 40-60% and increases therapeutic antibody titers, generating recurring licensing revenue from biopharmaceutical manufacturers.
Synthetic Biology of Cell-Based Drug Manufacturing Click to view more details →
Insulin and GLP-1 Analog Fermentation Scale-Up Services
A contract manufacturing service that applies synthetic biology to engineer optimized bacterial and yeast strains for cost-effective production of insulin, tirzepatide, and semaglutide analogs at commercial scale. This service captures 15-25% of manufacturing margins while serving the exploding $100B+ GLP-1 drug market.
Synthetic Biology of Cell-Based Drug Manufacturing Click to view more details →
Gene Therapy Vector Production Optimization Software Suite
A comprehensive software tool that optimizes mammalian cell bioreactor conditions and genetic circuits for high-titer AAV and lentiviral vector manufacturing with reduced off-target production. The platform enables customers to increase vector yields by 50-80% and reduce COGS, creating substantial SaaS subscription revenue from gene therapy manufacturers.
Synthetic Biology of Cell-Based Drug Manufacturing Click to view more details →
Biosimilar Manufacturing Process Development and Strain Engineering
An integrated service offering that designs and validates optimized cell lines and bioreactor processes for rapid biosimilar development targeting blockbuster biologics nearing patent expiration. This service captures multi-million dollar project fees while accelerating biosimilar time-to-market by 12-18 months for pharmaceutical partners.
Synthetic Biology of Cell-Based Drug Manufacturing Click to view more details →
Engineered Probiotics and Live Biotherapeutic Product Platform
A platform technology for engineering commensal bacteria to produce therapeutic payloads directly in the human microbiome, enabling oral delivery of biologics without injection. This addresses a $50B+ market opportunity in microbiome therapeutics while generating royalties on each therapeutic product developed using the platform.
Synthetic Biology of Cell-Based Drug Manufacturing Click to view more details →
Recombinant Protein Expression Yield Maximization Analytics Engine
An AI-powered analytics platform that predicts optimal codon usage, promoter selection, and fermentation parameters for maximizing recombinant protein production yields across E. coli, yeast, and insect cell systems. The platform enables customers to reduce protein manufacturing costs by 30-45% per gram, generating data licensing and subscription revenue from contract manufacturers and CDMOs.
Synthetic Biology of Cell-Based Drug Manufacturing Click to view more details →
Universal Regulatory Element Cross-Kingdom Transfer
Testing promoters and regulatory elements across bacteria, yeast, and mammalian chassis and measuring activity conservation and necessary adaptation strategies for cross-kingdom function.
Synthetic Biology of Chassis-Independent Parts Click to view more details →
Orthogonal Genetic System Development for Any Host
Creating TXTL system-based part characterization protocol for chassis-independent characterization and measuring prediction accuracy transfer from in vitro to diverse in vivo contexts.
Synthetic Biology of Chassis-Independent Parts Click to view more details →